Upcoming Stock Splits This Week (July 7 to July 11) – Stay Invested

These are the upcoming stock splits for the week of July 7 to July 11, based on TipRanks’ Stock Splits Calendar. For those new to the concept, a stock split is a corporate strategy that increases the number of shares in circulation by granting existing shareholders additional shares. While this move doesn’t change the company’s overall market value, it does lower the share price, making the stock more affordable, and often more appealing, to everyday investors.

But it’s not always about making shares cheaper. Some companies go in the opposite direction with a reverse stock split, combining shares to boost the price per share while reducing the total number. This maneuver, which also leaves the company’s market value untouched, is often used to meet exchange requirements and avoid the risk of delisting.

Whether the goal is to attract a broader base of investors or simply to stay in the game, these corporate moves can send important signals that savvy traders pay attention to.

Let’s take a look at the upcoming stock splits for the week.

Fly-E Group (FLYE) – Fly-E designs and sells smart electric motorcycles, bikes, and scooters for urban commuters and adventure-seekers alike. On July 2, the company announced a 1-for-5 reverse stock split to boost its share price and remain in compliance with Nasdaq listing standards. The split becomes effective July 7, when shares begin trading on a split-adjusted basis.

BioVie (BIVI) – BioVie is a biopharmaceutical innovator working to develop therapies for NASH and other serious fibrotic diseases. On June 26, the company approved a 1-for-10 reverse stock split aimed at raising the share price above Nasdaq’s minimum threshold. The split will be reflected in trading starting July 7.

Revelation Biosciences (REVB) – With its sights set on breakthrough treatments for chronic kidney disease, Revelation Biosciences is taking proactive steps to stay ahead. The company announced a 1-for-3 reverse stock split to meet Nasdaq’s listing standards, following approval at its Special Meeting of Stockholders held on June 23. The split will take effect on July 7.

Cyclacel Pharmaceuticals (CYCC) – Cyclacel Pharmaceuticals is a clinical-stage biotech working to create small-molecule cancer drugs that may redefine oncology treatment. On July 2, the company announced a 1-for-15 reverse stock split to keep its shares above Nasdaq’s minimum price requirement. The split will be in effect starting July 7.

Nuwellis (NUWE) – Nuwellis, a trailblazer in medical-tech fluid management tools for heart and kidney patients, has finalized its 1-for-42 reverse stock split. The split became effective after the close of business on July 3, and trading on a split-adjusted basis will begin at the open on Monday, July 7.

La Rosa Holdings (LRHC) – La Rosa is a real estate brokerage and PropTech company serving residential markets across the United States. On July 2, the company announced an 80-for-1 reverse stock split to comply with Nasdaq’s minimum bid price. The split will be effective July 7.

Banzai International (BNZI) – Banzai delivers essential marketing and sales technology solutions to businesses globally. On July 3, the company announced a 1‑for‑10 reverse stock split, designed to lift its per-share price and comply with Nasdaq’s $1 minimum bid requirement following a steep share-price decline. This split will be effective at market open on July 8.

Boqii Holding Limited (BQ) – Boqii is China’s leading e-commerce platform for pet products. On July 1, the company announced a 1‑for‑160 reverse stock split, consolidating every 160 ordinary shares into one and terminating its ADS facility to simplify its NYSE American listing. The split becomes effective on July 11.

To find more information about historical and upcoming stock splits, visit the TipRanks Stock Splits Calendar.